bluebird bio Inc Hits New 52-Week Low at $20.63 (BLUE)
bluebird bio (NASDAQ:BLUE)’s share price reached a new 52-week low during trading hours on Friday, Analyst Ratings Network.com reports. The company traded as low as $20.63 and last traded at $21.31, with a volume of 45,693 shares traded. The stock had previously closed at $21.25.
bluebird bio has a 1-year low of $24.00 and a 1-year high of $36.25. The stock has a 50-day moving average of $24.92 and a 200-day moving average of $27.22. The company’s market cap is $500.1 million.
bluebird bio (NASDAQ:BLUE) last released its earnings data on Thursday, August 8th. The company reported ($2.13) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.35) by $1.78. The company had revenue of $6.30 million for the quarter, compared to the consensus estimate of $4.85 million. The company’s quarterly revenue was up 6200.0% on a year-over-year basis. On average, analysts predict that bluebird bio will post $-1.34 earnings per share for the current fiscal year.
bluebird bio, Inc is a clinical-stage biotechnology company, the Company is focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.